119 related articles for article (PubMed ID: 36500230)
1. Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico Studies.
Haroun M; Petrou A; Tratrat C; Kolokotroni A; Fesatidou M; Zagaliotis P; Gavalas A; Venugopala KN; Sreeharsha N; Nair AB; Elsewedy HS; Geronikaki A
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500230
[TBL] [Abstract][Full Text] [Related]
2. Dual COX-2 and 15-LOX inhibition study of novel 4-arylidine-2-mercapto-1-phenyl-1H-imidazolidin-5(4H)-ones: Design, synthesis, docking, and anti-inflammatory activity.
Osman NA; Soltan MK; Rezq S; Flaherty J; Romero DG; Abdelkhalek AS
Arch Pharm (Weinheim); 2024 May; 357(5):e2300615. PubMed ID: 38315093
[TBL] [Abstract][Full Text] [Related]
3. Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation.
Said MF; Marie SM; Mohamed NM; Mahrouse MA; Moussa BA
Future Med Chem; 2024; 16(9):817-842. PubMed ID: 38634318
[TBL] [Abstract][Full Text] [Related]
4. Exploring new imines as anti-inflammatory COX and 5-LOX inhibitors with an improved pharmacokinetic profile.
Said MF; Moussa BA; Mahrouse MA; Marie SM; Mohamed NM
Future Med Chem; 2024 Feb; 16(4):311-334. PubMed ID: 38293746
[No Abstract] [Full Text] [Related]
5. Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
Sisa M; Dvorakova M; Temml V; Jarosova V; Vanek T; Landa P
Eur J Med Chem; 2020 Oct; 204():112620. PubMed ID: 32738413
[TBL] [Abstract][Full Text] [Related]
6. Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors.
Noti V; Pontiki E; Hadjipavlou-Litina D
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138448
[TBL] [Abstract][Full Text] [Related]
7. Thiazoles and Thiazolidinones as COX/LOX Inhibitors.
Liaras K; Fesatidou M; Geronikaki A
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562646
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with
El-Miligy MMM; Al-Kubeisi AK; Nassra RA; El-Zemity SR; Hazzaa AA
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2309171. PubMed ID: 38291670
[TBL] [Abstract][Full Text] [Related]
9. Novel Series of Methyl 3-(Substituted Benzoyl)-7-Substituted-2-Phenylindolizine-1-Carboxylates as Promising Anti-Inflammatory Agents: Molecular Modeling Studies.
Venugopala KN; Al-Attraqchi OHA; Tratrat C; Nayak SK; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Venugopala R; Haroun M; Girish MB; Chandrashekharappa S; Alwassil OI; Odhav B
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31661893
[TBL] [Abstract][Full Text] [Related]
10. Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches.
Hemavathi KN; Skariyachan S; Raju R; Keshava Prasad TS; Abhinand CS
Comput Biol Med; 2024 Mar; 171():108164. PubMed ID: 38412690
[TBL] [Abstract][Full Text] [Related]
11. First report of substituted 2
Chakraborty K; Dhara S
Nat Prod Res; 2020 Dec; 34(24):3451-3461. PubMed ID: 30835545
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of New Benzophenone Derivatives with In Vivo Anti-Inflammatory Activity through Dual Inhibition of Edema and Neutrophil Recruitment.
Januario JP; de Souza TB; Lavorato SN; Maiolini TCS; Domingos OS; Baldim JL; Folquitto LRS; Soares MG; Chagas-Paula DA; Dias DF; Dos Santos MH
Molecules; 2018 Jul; 23(8):. PubMed ID: 30049981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and anti-inflammatory properties of novel ethyl 3-benzoyl-7-(trifluoromethyl)indolizine-1-carboxylate derivatives: In silico and in vitro analysis.
Singh HR; Kushwaha P; Tandon R; Srivastava N; Chandrashekharappa S
Chem Biol Drug Des; 2024 Mar; 103(3):e14514. PubMed ID: 38531606
[TBL] [Abstract][Full Text] [Related]
14. Development of safe and antioxidant COX-2 inhibitors; Synthesis, molecular docking analysis and biological evaluation of novel pyrrolizine 5-carboxamides.
K A Abdelall E; Elshemy HAH; Philoppes JN; Abdel-Fattah MM; El-Nahaas ES; Mahmoud RR
Bioorg Chem; 2024 Feb; 143():107098. PubMed ID: 38185010
[TBL] [Abstract][Full Text] [Related]
15. New insights into the anti-inflammatory and anti-melanoma mechanisms of action of azelaic acid and other Fusarium solani metabolites via in vitro and in silico studies.
Ismail M; Hassan MHA; Mohamed EIA; Azmy AF; Moawad A; Mohammed R; Zaki MA
Sci Rep; 2024 Jun; 14(1):14370. PubMed ID: 38909081
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity.
Maniewska J; Wiatrak B; Czyżnikowska Ż; Szczęśniak-Sięga BM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360585
[TBL] [Abstract][Full Text] [Related]
17.
Kumar M; Rani I; Mujwar S; Narang R; Devgun M; Khokra SL
Assay Drug Dev Technol; 2023; 21(4):166-179. PubMed ID: 37318837
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Biological, Spectroscopic and Computational Investigations of Novel
Mikus J; Świątek P; Przybyła P; Krzyżak E; Marciniak A; Kotynia A; Redzicka A; Wiatrak B; Jawień P; Gębarowski T; Szczukowski Ł
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513351
[TBL] [Abstract][Full Text] [Related]
19. Precise cuts for tailoring chromene-phenyl COX inhibitors with Ligand Designer.
Vo HHN; Phung THT; Chung KL; Vu TY
J Mol Graph Model; 2024 Jun; 129():108747. PubMed ID: 38447296
[TBL] [Abstract][Full Text] [Related]
20. Experimental investigation and molecular simulations of quinone related compounds as COX/LOX inhibitors.
Chaaban I; Hafez H; Hazzaa A; Domiati S; Abd El Galil KH; Hdeib F; Belal ASF; Ragab H
Inflammopharmacology; 2024 Jun; ():. PubMed ID: 38858336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
